Prostate Cancer - Results from #860

REVIEW UroToday

Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer, "Beyond the Abstract," by N. Vasiljević, A. S. Ahmad, and A. T. Lorincz August 27, 2013

Extracting data from electronic medical records: Validation of a natural language processing program to assess prostate biopsy results, "Beyond the Abstract," by Anil A. Thomas, MD and Gary W. Chien, MD August 27, 2013

Monitor unit optimization in RapidArc plans for prostate cancer, "Beyond the Abstract," by Stefania Clemente August 22, 2013

Long-term prostate-specific antigen velocity in improved classification of prostate cancer risk and mortality, "Beyond the Abstract," by David D. Ørsted, MD, PhD fellow August 21, 2013

Betulinic acid: The potential of an effective, non-toxic, and clinically-selective agent for the treatment of CRPC, "Beyond the Abstract," by Carlos Perez-Stable, PhD August 20, 2013

A single surgeon's series in Japan: Predictors for positive surgical margins after robot-assisted radical prostatectomy, "Beyond the Abstract," by Takeshi Hashimoto, Kunihiko Yoshioka, Jun Nakashima, and Masaaki Tachibana August 20, 2013

Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: An external validation, "Beyond the Abstract," by Mauro Gacci and Michele Lanciotti August 20, 2013

Metabolic manipulation as a new tool for prostate cancer treatment, "Beyond the Abstract," by Lluis Fajas August 15, 2013

PSA testing by Dutch general practitioners: Impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC), "Beyond the Abstract," by Marco H. Blanker, MD, PhD and Saskia van der Meer, MD August 14, 2013

PET imaging in prostate cancer: Focus on prostate-specific membrane antigen, "Beyond the Abstract," by Ron Rodriguez, MD, PhD August 14, 2013

Technique, cancer control, and morbidity in prostate brachytherapy in men with gland volume of 100cc or greater, "Beyond the Abstract," by Nelson Neal Stone, MD August 8, 2013

Real-time individual predictions of prostate cancer recurrence using joint models, "Beyond the Abstract," by Jeremy M. G. Taylor, PhD August 7, 2013

Repeat prostate biopsy strategies after initial negative biopsy: Meta-regression comparing cancer detection of transperineal, transrectal saturation and MRI guided biopsy, "Beyond the Abstract," by Adam W. Nelson and Vincent J. Gnanapragasam August 6, 2013

Predictors of biochemical failure in patients undergoing prostate whole-gland salvage cryotherapy: A novel risk stratification model, "Beyond the Abstract," by Philippe E. Spiess, MD, MSc, FACS, FRCS(C) August 1, 2013

The effect of estrogen on the sexual interest of castrated males: Implications to prostate cancer patients on androgen-deprivation therapy, "Beyond the Abstract," by Erik Wibowo and Richard J. Wassersug July 31, 2013

Contrast-enhanced ultrasound (CEUS) as support for prostate brachytherapy treatment planning, "Beyond the Abstract," by Bradley Pieters, MD, PhD, et al July 30, 2013

Focal therapy is appropriate in the treatment of highly selected patients with localized prostate cancer and has an acceptably low rate of morbidity and complications, "Beyond the Abstract," by Youness Ahallal, Rafael Sanchez-Salas, and Eric Barret July 24, 2013

Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer, "Beyond the Abstract," by Nelma Pértega-Gomes and Fátima Baltazar July 23, 2013

Management of prostate cancer patients receiving androgen deprivation therapy while undergoing radiation therapy, "Beyond the Abstract," by Mark Buyyounouski, MD, MS July 22, 2013

Common genetic variation of the calcium sensing receptor and lethal prostate cancer risk, "Beyond the Abstract," by Irene M. Shui and Kathryn M. Wilson July 20, 2013

Page 44 of 57